Immupharma PLC Directorate Change (6273A)
September 30 2015 - 1:05AM
UK Regulatory
TIDMIMM
RNS Number : 6273A
Immupharma PLC
30 September 2015
FOR IMMEDIATE RELEASE 30 SEPTEMBER 2015
TIM MCCARTHY APPOINTED AS NON-EXECUTIVE CHAIRMAN
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, is pleased to
announce the appointment of Tim McCarthy as Non-executive Chairman,
with immediate effect.
Mr McCarthy has a 35 year international business career in high
growth biotech, healthcare and technology companies. He is
currently Chairman and Non-Executive Director for a number of
biotech and healthcare related companies, including Incanthera,
Harvard Healthcare and Expedeon Holdings. Mr McCarthy is also the
former Chief Executive Officer and Finance Director of a number UK
listed public and private companies, including Alizyme plc and
Peptide Therapeutics Group plc, and has a core understanding of AIM
and its regulatory processes. Co-founding a number of healthcare
and biotechnology companies, Mr McCarthy has helped raise
substantial amounts of equity capital and also advised and worked
at Board level for a diverse range of companies internationally, in
areas such as business strategy, mergers & acquisitions, due
diligence and licensing.
A Fellow of the Association of Chartered Certified Accountants,
Mr McCarthy has an MBA from Cranfield School of Management.
Commenting on Tim McCarthy's appointment, Dimitri Dimitrou,
Chief Executive Officer, said:
"We are delighted to have Tim join ImmuPharma as Chairman. This
appointment represents a further strong addition to the Board.
Tim's commercial and industry background together with capital
markets experience will be extremely valuable as ImmuPharma
progresses its lead compound, Lupuzor(TM) , through its pivotal
Phase III trial, as well as providing guidance on ImmuPharma's long
term business strategy."
Current Directorships
Ark Analytics Solutions Limited
BBN International Limited
Dropped Limited
Expedeon Holdings Limited
Frangipani Dreams Limited
Harvard Healthcare Limited
Incanthera Limited
Spear Therapeutics Limited
Unnamed Limited
Wise Old Owl Limited
Directorships in the Last 5 years
Retail Service Team Limited*
*This company entered into a Creditors Voluntary Winding-up on
12(th) December 2013, 8 months after Mr McCarthy's resignation of
directorship. It was dissolved on 4 June 2015.
There are no other disclosures required in relation to Rule 17
or paragraph (g) of Schedule 2 of the AIM Rules for Companies.
For further information please contact:
+ 44 (0) 20
ImmuPharma plc 7152 4080
Dimitri Dimitriou, Chief Executive
Officer
Lisa Baderoon, Head of Investor + 44 (0) 7721
Relations 413 496
Panmure, Gordon & Co., NOMAD & + 44 (0) 20
Broker 7886 2500
Fred Walsh, Duncan Monteith, Corporate
Finance
Charles Leigh-Pemberton, Corporate
Broking
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAPKCDNOBKDNCB
(END) Dow Jones Newswires
September 30, 2015 02:05 ET (06:05 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024